APOE and Alzheimer disease: While previous multisite research has shown associations between AD biomarkers and specific genetic variations (such as APOE, APP, PSEN1, and PSEN2) [5]–[11], in most research studies and in routine practice, clinicians usually rely on a simple “yes/no” of self-reported FH status.